Clinical Trials Browser

Phase 3 × Has results × anamorelin × Clear all

NCT03743051 2024-06-26

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Completed

318 enrolled 28 charts

Cachexia, Carcinoma, Non-Small-Cell Lung, Neoplasms